Abstract | PURPOSE: The objective of this study was to evaluate subfoveal choroidal thickness (SFCT) using enhanced depth imaging optical coherence tomography (EDI-OCT) in patients with naïve branch retinal vein occlusion (BRVO) before and after intravitreal dexamethasone implant (Ozurdex®) injection. METHODS: Thirty-nine patients with unilateral BRVO and 35 healthy subjects were included in this prospective study. Choroidal thickness was evaluated by EDI-OCT at baseline and 1 month after dexamethasone implant. RESULTS: The mean SFCT measured in 39 patients with BRVO was 299.41 ± 55.86 µm, significantly greater than that in contralateral eyes (283.76 ± 57.44 µm; p=0.009) and control eyes (276.14 ± 39.06 µm; p=0.044). The mean SFCT after the treatment was 279.64 ± 50.96 µm, significantly thinner than that before intravitreal dexamethasone therapy (p=0.004). CONCLUSIONS: SFCT in treatment-naive BRVO eyes was significantly greater than that in contralateral eyes and healthy eyes and decreased significantly after intravitreal dexamethasone implantation.
|
Authors | Hasan Basri Arifoglu, Necati Duru, Orhan Altunel, Burhan Baskan, Bedirhan Alabay, Mustafa Atas |
Journal | Arquivos brasileiros de oftalmologia
(Arq Bras Oftalmol)
2016 Jul-Aug
Vol. 79
Issue 4
Pg. 243-6
ISSN: 1678-2925 [Electronic] Brazil |
PMID | 27626149
(Publication Type: Journal Article)
|
Chemical References |
- Glucocorticoids
- Dexamethasone
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Case-Control Studies
- Choroid
(diagnostic imaging, drug effects)
- Dexamethasone
(administration & dosage)
- Female
- Glucocorticoids
(administration & dosage)
- Humans
- Intraocular Pressure
- Intravitreal Injections
- Macular Edema
(prevention & control)
- Male
- Middle Aged
- Prospective Studies
- Reference Values
- Retinal Vein Occlusion
(diagnostic imaging, drug therapy)
- Statistics, Nonparametric
- Time Factors
- Tomography, Optical Coherence
(methods)
- Treatment Outcome
- Visual Acuity
|